Eurofins Scientific SE
Healthcare · EUR · EPA
Price
€61.94
Cap
€1.45B
Earnings
—
30d Trend
+2.6%
32% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 48×Macro 0.99 (−1%)=48
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Eurofins Scientific SE at 48/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 57/100. I classify this as a growth position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+3.3%
3 MONTHS
-8.3%
12 MONTHS
+10.1%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Momentum (57) and Technical (57) are the primary strengths. I note that quality is the weakest area at 28/100 — this warrants monitoring. Historical volatility is moderate at 32%. I classify this as a growth position — positive trend direction combined with growth potential points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.